EP Patent

EP2656854A1 — Uses of aromatic-cationic peptide

Assigned to Institut de Recherches Cliniques de Montreal IRCM · Expires 2013-10-30 · 13y expired

What this patent protects

The present invention relates to a specific aromatic-cationic peptide that is useful in clinical applications such as for increasing cardiac contractility in a subject and inhibiting cardiac stunning in a subject. The peptide can also be used to enhance the preservation of a remo…

USPTO Abstract

The present invention relates to a specific aromatic-cationic peptide that is useful in clinical applications such as for increasing cardiac contractility in a subject and inhibiting cardiac stunning in a subject. The peptide can also be used to enhance the preservation of a removed organ.

Drugs covered by this patent

Patent Metadata

Patent number
EP2656854A1
Jurisdiction
EP
Classification
—
Expires
2013-10-30
Drug substance claim
No
Drug product claim
No
Assignee
Institut de Recherches Cliniques de Montreal IRCM
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.